A second phase 2a, dose escalation study of Factor VIIa-CTP in patients with haemophilia A or B

Trial Profile

A second phase 2a, dose escalation study of Factor VIIa-CTP in patients with haemophilia A or B

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2016

At a glance

  • Drugs Factor VIIa-CTP (Primary) ; Factor VIIa-CTP (Primary)
  • Indications Haemophilia A; Haemophilia B
  • Focus Adverse reactions; First in man
  • Sponsors OPKO Health
  • Most Recent Events

    • 07 Nov 2016 According to an OPKO health media release, safety data from this trial expected in early 2017.
    • 29 Feb 2016 According to an OPKO health media release, first patient has been dosed in this trial.
    • 29 Feb 2016 Status changed from not yet recruiting to recruiting, according to an OPKO Health media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top